Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Cohen Eliav M, Skorochod Y, Breuer GS, Tur-Kaspa R, Weil Wiener Y, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Jan 15;14(1):e0210173. doi: 10.1371/journal.pone.0210173. eCollection 2019.

PMID:
30645600
2.

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease.

Harari S.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180110. doi: 10.1183/16000617.0110-2018. Print 2018 Dec 31. No abstract available.

3.

The changing face of the European Respiratory Review.

Harari S.

Eur Respir Rev. 2018 Dec 19;27(150). pii: 180102. doi: 10.1183/16000617.0102-2018. Print 2018 Dec 31. No abstract available.

4.

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.

van Cleemput J, Sonaglioni A, Wuyts WA, Bengus M, Stauffer JL, Harari S.

Adv Ther. 2018 Dec 15. doi: 10.1007/s12325-018-0857-z. [Epub ahead of print] Review.

PMID:
30554332
5.

Pulmonary hypertension in chronic lung disease and hypoxia.

Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W.

Eur Respir J. 2018 Dec 13. pii: 1801914. doi: 10.1183/13993003.01914-2018. [Epub ahead of print]

6.

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.

Gonano C, Pasquier J, Daccord C, Johnson SR, Harari S, Leclerc V, Falconer L, Miano E, Cordier JF, Cottin V, Lazor R.

Orphanet J Rare Dis. 2018 Dec 13;13(1):222. doi: 10.1186/s13023-018-0964-6.

7.

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy.

Schlafstein AJ, Withers AE, Rudra S, Danelia D, Switchenko JM, Mister D, Harari S, Zhang H, Daddacha W, Ehdaivand S, Li X, Torres MA, Yu DS.

Int J Breast Cancer. 2018 Oct 14;2018:6945129. doi: 10.1155/2018/6945129. eCollection 2018.

8.

Randomised controlled trials and real-life studies: two answers for one question.

Harari S.

Eur Respir Rev. 2018 Sep 26;27(149). pii: 180080. doi: 10.1183/16000617.0080-2018. Print 2018 Sep 30. No abstract available.

9.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

PMID:
30249391
10.

Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.

Harari S, Spagnolo P, Cocconcelli E, Luisi F, Cottin V.

Curr Opin Pulm Med. 2018 Sep;24(5):469-476. doi: 10.1097/MCP.0000000000000502.

PMID:
29927757
11.

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.

Behr J, Nathan SD, Harari S, Wuyts W, Kirchgaessler KU, Bengus M, Gilberg F, Wells AU.

Respir Med. 2018 May;138:13-20. doi: 10.1016/j.rmed.2018.03.019. Epub 2018 Mar 16.

12.

Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.

Sonaglioni A, Baravelli M, Cassandro R, Torre O, Elia D, Anzà C, Harari S.

J Am Soc Echocardiogr. 2018 Aug;31(8):888-901. doi: 10.1016/j.echo.2018.02.004. Epub 2018 Mar 28.

PMID:
29605474
13.

A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.

Harari S, Caminati A, Poletti V, Confalonieri M, Gasparini S, Lacedonia D, Luppi F, Pesci A, Sebastiani A, Spagnolo P, Vancheri C, Balestro E, Bonifazi M, Cerri S, De Giacomi F, Della Porta R, Foschino Barbaro MP, Fui A, Pasquinelli P, Rosso R, Tomassetti S, Specchia C, Rottoli P; for the ILDINET (Interstitial Lung Diseases Italian Network).

Respiration. 2018;95(6):433-440. doi: 10.1159/000487711. Epub 2018 Mar 27.

PMID:
29587263
14.

Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension.

Farina S, Bruno N, Agalbato C, Contini M, Cassandro R, Elia D, Harari S, Agostoni P.

Int J Cardiol. 2018 May 15;259:178-182. doi: 10.1016/j.ijcard.2017.11.023.

PMID:
29579597
15.

Validation of multidisciplinary diagnosis in IPF.

Castillo D, Walsh S, Hansell DM, Vasakova M, Cottin V, Altinisik G, Palmucci S, Sterclova M, Harari S, Richeldi L, Vancheri C, Wells AU; ERICE ILD working group.

Lancet Respir Med. 2018 Feb;6(2):88-89. doi: 10.1016/S2213-2600(18)30023-7. Review. No abstract available.

PMID:
29413085
16.

The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Steagall WK, Pacheco-Rodriguez G, Darling TN, Torre O, Harari S, Moss J.

Am J Respir Cell Mol Biol. 2018 Jun;58(6):678-683. doi: 10.1165/rcmb.2017-0403TR.

PMID:
29406787
17.

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, Pilotto S, Harari S, Papotti M, Volante M, Fontanini G, Mastracci L, Albini A, Bria E, Calabrese F, Scarpa A.

Virchows Arch. 2018 Apr;472(4):567-577. doi: 10.1007/s00428-018-2307-3. Epub 2018 Feb 1.

PMID:
29388013
18.

The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy.

Conti S, Harari S, Caminati A, Zanobetti A, Schwartz JD, Bertazzi PA, Cesana G, Madotto F.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700397. doi: 10.1183/13993003.00397-2017. Print 2018 Jan.

PMID:
29371377
19.

Severe idiopathic pulmonary fibrosis: A clinical approach.

Lipsi R, Mazzola D, Caminati A, Elia D, Lonati C, Harari S.

Eur J Intern Med. 2018 Apr;50:20-27. doi: 10.1016/j.ejim.2018.01.014. Epub 2018 Feb 1. Review.

PMID:
29361476
20.

Pulmonary hypertension: a paradigm for rare pulmonary diseases.

Harari S.

Eur Respir Rev. 2017 Dec 20;26(146). pii: 170120. doi: 10.1183/16000617.0120-2017. Print 2017 Dec 31. No abstract available.

21.

Recent advances in managing idiopathic pulmonary fibrosis.

Scelfo C, Caminati A, Harari S.

F1000Res. 2017 Nov 27;6:2052. doi: 10.12688/f1000research.10720.1. eCollection 2017. Review.

22.

Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.

Montefusco L, Harari S, Elia D, Rossi A, Specchia C, Torre O, Adda G, Arosio M.

Eur J Intern Med. 2018 May;51:61-67. doi: 10.1016/j.ejim.2017.11.011. Epub 2017 Dec 1.

PMID:
29198444
23.

Classification of pulmonary neuroendocrine tumors: new insights.

Pelosi G, Sonzogni A, Harari S, Albini A, Bresaola E, Marchiò C, Massa F, Righi L, Gatti G, Papanikolaou N, Vijayvergia N, Calabrese F, Papotti M.

Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04. Review.

24.

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.

Torre O, Elia D, Caminati A, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170042. doi: 10.1183/16000617.0042-2017. Print 2017 Sep 30. Review.

25.

Severe idiopathic pulmonary fibrosis: what can be done?

Caminati A, Cassandro R, Torre O, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170047. doi: 10.1183/16000617.0047-2017. Print 2017 Sep 30. Review.

26.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Caliò A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.

Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.

27.

Rare pulmonary diseases: a common fight.

Harari S, Humbert M.

Eur Respir Rev. 2017 Sep 6;26(145). pii: 170059. doi: 10.1183/16000617.0059-2017. Print 2017 Sep 30. No abstract available.

28.

Current understanding and management of pulmonary Langerhans cell histiocytosis.

Vassallo R, Harari S, Tazi A.

Thorax. 2017 Oct;72(10):937-945. doi: 10.1136/thoraxjnl-2017-210125. Epub 2017 Jul 8. Review.

PMID:
28689173
29.

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

Harari SE, Sassoon DJ, Priemer DS, Jacob JM, Eble JN, Caliò A, Grignon DJ, Idrees M, Albany C, Masterson TA, Hanna NH, Foster RS, Ulbright TM, Einhorn LH, Cheng L.

Urol Oncol. 2017 Oct;35(10):605.e9-605.e16. doi: 10.1016/j.urolonc.2017.05.018. Epub 2017 Jun 21. Review.

PMID:
28647396
30.

Pulmonary Hypertension in Parenchymal Lung Diseases: Any Future for New Therapies?

Harari S, Elia D, Humbert M.

Chest. 2018 Jan;153(1):217-223. doi: 10.1016/j.chest.2017.06.008. Epub 2017 Jun 16. Review.

PMID:
28629920
31.

The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps.

Harari S, Cassandro R, Torre O.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):659-660. doi: 10.1164/rccm.201702-0272LE. No abstract available.

PMID:
28288282
32.

Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.

Harari S, Caminati A, Madotto F, Conti S, Cesana G.

Eur Respir J. 2017 Jan 25;49(1). pii: 1601504. doi: 10.1183/13993003.01504-2016. Print 2017 Jan. No abstract available.

33.

Out with the old, in with the new for the European Respiratory Review.

Harari S.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160118. doi: 10.1183/16000617.0118-2016. Print 2017 Jan. No abstract available.

34.

The revolution of pulmonary arterial hypertension.

Harari S.

Eur Respir Rev. 2016 Dec;25(142):361-363. doi: 10.1183/16000617.0102-2016. No abstract available.

35.

99mTc-Sestamibi Avid Soft Tissue Lesions in Rosai-Dorfman Disease.

Wong PK, Lee DJ, Harari S, Barron BJ.

Clin Nucl Med. 2016 Dec;41(12):e508-e510.

PMID:
27824326
36.

Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective.

Bassi I, Hollis G, Cottin V, Harari S, Zwanenburg E, Veltkamp M, Casanova A, Fletcher M, Masefield S, Powell P, Boyd J.

ERJ Open Res. 2016 Apr 21;2(2). pii: 00102-2015. eCollection 2016 Apr.

37.

Adding new perspectives to the European Respiratory Review.

Harari S.

Eur Respir Rev. 2016 Sep;25(141):221-2. doi: 10.1183/16000617.0045-2016. No abstract available.

38.

Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.

Harari S, Elia D, Torre O, Bulgheroni E, Provasi E, Moss J.

Chest. 2016 Aug;150(2):e29-32. doi: 10.1016/j.chest.2016.02.654.

39.

Data sharing: When better may be the enemy of good.

Harari S.

Eur J Intern Med. 2016 Sep;33:e28-9. doi: 10.1016/j.ejim.2016.06.003. Epub 2016 Jun 28. No abstract available.

PMID:
27363305
40.

Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis).

Luisi F, Torre O, Harari S.

Eur Respir Rev. 2016 Jun;25(140):170-7. doi: 10.1183/16000617.0018-2016. Review.

41.

Why we should care about ultra-rare disease.

Harari S.

Eur Respir Rev. 2016 Jun;25(140):101-3. doi: 10.1183/16000617.0017-2016. No abstract available.

42.

Toward better management of rare and orphan pulmonary diseases.

Harari S, Humbert M.

Eur Respir J. 2016 May;47(5):1334-5. doi: 10.1183/13993003.00390-2016. No abstract available.

43.

The goal is to go further and do better: but how?

Harari S.

Eur Respir Rev. 2016 Mar;25(139):1-3. doi: 10.1183/16000617.0094-2015. No abstract available.

44.

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.

Harari S, Madotto F, Caminati A, Conti S, Cesana G.

PLoS One. 2016 Feb 3;11(2):e0147072. doi: 10.1371/journal.pone.0147072. eCollection 2016.

45.

Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis.

Harari SE, Cheng L, Osunkoya AO.

Hum Pathol. 2016 Jan;47(1):132-7. doi: 10.1016/j.humpath.2015.09.014. Epub 2015 Sep 30.

PMID:
26552875
46.

The changing face of a rare disease: lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Moss J.

Eur Respir J. 2015 Nov;46(5):1471-85. doi: 10.1183/13993003.00412-2015. Epub 2015 Sep 24. Review.

47.

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation.

Caminati A, Madotto F, Cesana G, Conti S, Harari S.

Eur Respir Rev. 2015 Sep;24(137):436-44. doi: 10.1183/16000617.0040-2015. Review.

48.

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences.

Harari S, Caminati A.

Eur Respir Rev. 2015 Sep;24(137):420-7. doi: 10.1183/16000617.0042-2015. Review.

49.

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

Adir Y, Elia D, Harari S.

Eur Respir Rev. 2015 Sep;24(137):400-10. doi: 10.1183/16000617.0041-2015. Review.

50.

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

Harari S, Humbert M, Blasi F, Collard HR, Matucci-Cerinic M, Simonneau G, Vancheri C, Wells AU, Cottin V.

Eur Respir Rev. 2015 Sep;24(137):375-7. doi: 10.1183/16000617.0051-2015. No abstract available.

Supplemental Content

Loading ...
Support Center